Home LiteratureArticle Details
PMID: 15558498 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Regression mapping of association between the human leukocyte antigen region and Graves disease.

American journal of human genetics ·Vol. 76 ·No. 1 ·2005-01-00 ·Pages 157-63

Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC

Abstract

The human leukocyte antigen class II genes DRB1, DQB1, and DQA1 are associated with Graves disease (GD), but, because of strong linkage disequilibrium within this region, the primary etiological variant(s) remains unknown. In the present study, 871 patients with GD and 621 control subjects were genotyped at the DRB1, DQB1, and DQA1 loci. All three loci were associated with GD (P=1.45 x 10(-12), P=3.20 x 10(-5), and P=9.26 x 10(-12), respectively). Stepwise logistic-regression analysis showed that the association could be explained by either DRB1 or DQA1 but not by DQB1. To extend previous results, the amino acid sequence of the exon 2-encoded peptide-binding domain of DRB1 was predicted for each subject, and, by use of logistic regression, each position was analyzed for association with GD. Of 102 amino acids, 70 were uninformative; of the remaining 32 amino acids, 13 were associated with GD (P values ranged from 2.20 x 10(-4) to 1.2 x 10(-12)). The strongest association was at position beta 74. This analysis is consistent with the possibility that position beta 74 of exon 2 of the DRB1 molecule may have a specific and central role in autoantigen presentation by DRB1 to T lymphocytes. However, we cannot yet exclude a primary role for DQA1 or for other polymorphisms that affect DRB1 function or expression.

MeSH Terms
Case-Control Studies Chromosome Mapping Genes, MHC Class II Genotype Graves Disease/genetics HLA-DQ Antigens/genetics HLA-DQ alpha-Chains HLA-DQ beta-Chains HLA-DR Antigens/genetics Histocompatibility Antigens Class II Humans Odds Ratio Polymorphism, Genetic Regression Analysis
Chemicals
HLA-DQ Antigens HLA-DQ alpha-Chains HLA-DQ beta-Chains HLA-DQA1 antigen HLA-DQB1 antigen HLA-DR Antigens Histocompatibility Antigens Class II
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Simmonds Matthew J
Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, and Birmingham Heartlands Hospital, Birmingham B9 5SS, United Kingdom.
Howson Joanna M M
Heward Joanne M
Cordell Heather J
Foxall Helen
Carr-Smith Jackie
Gibson Sarah M
Walker Neil
Tomer Yaron
Franklyn Jayne A
Todd John A
Gough Stephen C L
References (24)
24 references, click to expand
  1. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions.
    J Clin Endocrinol Metab. 1999 Dec;84(12):4656-64 PMID: 10599734
  2. The genetics of Graves' disease.
    Endocrinol Metab Clin North Am. 2000 Jun;29(2):255-66 PMID: 10874528
  3. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.
    Hum Mol Genet. 2001 Jun 15;10(13):1379-86 PMID: 11440990
  4. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.
    Hum Mol Genet. 2001 Sep 15;10(19):2025-37 PMID: 11590120
  5. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.
    Am J Hum Genet. 2002 Jan;70(1):124-41 PMID: 11719900
  6. Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism.
    J Immunol. 2003 May 1;170(9):4683-92 PMID: 12707347
  7. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
    Nature. 2003 May 29;423(6939):506-11 PMID: 12724780
  8. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease.
    Genes Immun. 2004 May;5(3):203-8 PMID: 15029234
  9. HLA antigens in Graves' disease.
    Acta Endocrinol (Copenh). 1977 Nov;86(3):510-6 PMID: 72471
  10. The spectrum of thyroid disease in a community: the Whickham survey.
    Clin Endocrinol (Oxf). 1977 Dec;7(6):481-93 PMID: 598014
  11. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.
    Arthritis Rheum. 1987 Nov;30(11):1205-13 PMID: 2446635
  12. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.
    Diabetologia. 1992 May;35(5):419-24 PMID: 1521722
  13. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population.
    Diabetologia. 1993 Mar;36(3):252-7 PMID: 8462775
  14. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population.
    J Clin Endocrinol Metab. 1993 Jun;76(6):1569-74 PMID: 8501164
  15. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia.
    Hum Immunol. 1993 Jun;37(2):85-94 PMID: 8226139
  16. Autoimmune thyroid disease: further developments in our understanding.
    Endocr Rev. 1994 Dec;15(6):788-830 PMID: 7705281
  17. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.
    J Clin Invest. 1995 May;95(5):2120-6 PMID: 7738179
  18. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci.
    Hum Immunol. 1995 Aug;43(4):301-8 PMID: 7499178
  19. Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
    Eur J Immunol. 1996 Apr;26(4):949-52 PMID: 8625994
  20. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).
    Tissue Antigens. 1995 Nov;46(5):355-67 PMID: 8838344
  21. HLA-DRB1 alleles genotyping in patients with rheumatoid arthritis in Chinese.
    Chin Med Sci J. 1996 Dec;11(4):232-5 PMID: 9387389
  22. A roadmap for HLA-DR peptide binding specificities.
    Hum Immunol. 1997 Dec;58(2):61-9 PMID: 9475335
  23. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
    J Clin Endocrinol Metab. 1998 Oct;83(10):3394-7 PMID: 9768636
  24. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.
    J Clin Endocrinol Metab. 1999 Sep;84(9):3182-6 PMID: 10487684
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
2005-01-00
Epub
2004-00-22
Pages
157-63
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1196419
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]